Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 39, 2009 - Issue 7
158
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers

, , , , , , , & show all
Pages 508-513 | Received 19 Feb 2009, Accepted 07 Apr 2009, Published online: 12 May 2009

References

  • Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF. (1992). Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2:116–27.
  • Chirulli V, Marvasi L, Zaghini A, Fiorio R, Longo V, Gervasi PG. (2007). Inducibility of AhR-regulated CYP genes by beta-naphthoflavone in the liver, lung, kidney and heart of the pig. Toxicology 240:25–37.
  • Dasgupta A, Actor JK, Olsen M, Wells A, Datta P. (2002). In vivo digoxin-like immunoreactivity in mice and interference of Chinese medicine Danshen in serum digoxin measurement: elimination of interference by using a chemiluminescent assay. Clin Chim Acta 317:231–4.
  • Diani-Moore S, Papachristou F, Labitzke E, Rifkind AB. (2006). Induction of CYP1A and cyp2-mediated arachidonic acid epoxygenation and suppression of 20-hydroxyeicosatetraenoic acid by imidazole derivatives including the aromatase inhibitor vorozole. Drug Metab Dispos 34:1376–85.
  • Erichsen TJ, Ehmer U, Kalthoff S, Lankisch TO, Müller TM, Munzel PA, Manns MP, Strassburg CP. (2008). Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT)1A4 gene. Toxicol Appl Pharmacol 230:252–60.
  • Fukami T, Nakajima M, Sakai H, Katoh M, Yokoi T. (2007). CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline. Drug Metab Dispos 35:335–9.
  • Grant DM, Tang BK, Kalow W. (1983). Variability in caffeine metabolism. Clin Pharmacol Ther 33:591–602.
  • Ji X, Tan BK, Zhu YC, Linz W, Zhu YZ. (2003). Comparison of cardioprotective effects using ramipril and Danshen for the treatment of acute myocardial infarction in rats. Life Sci 73:1413–26.
  • Khan AY, Preskorn SH. (2005). Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring. J Psychiatr Pract 11:289–301.
  • Korashy HM, El-Kadi AO. (2006). The role of aryl hydrocarbon receptor and the reactive oxygen species in the modulation of glutathione transferase by heavy metals in murine hepatoma cell lines. Chem Biol Interact 162:237–48.
  • Lee WY, Chiu LC, Yeung JH. (2008). Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation. Food Chem Toxicol 46:328–38.
  • Liu J, Wang X, Cai Z, Lee FS. (2008). Effect of tanshinone II A on the noncovalent interaction between warfarin and human serum albumin studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 19:1568–75.
  • Ou-Yang DS, Huang SL, Wang W, Xie HG, Xu ZH, Shu Y, Zhou HH. (2000). Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol 49:145–51.
  • Qiu F, Zhang R, Sun J, Jiye A, Hao H, Peng Y, Ai H, Wang G. (2008). Inhibitory effects of seven components of Danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metab Dispos 36:1308–14.
  • Qiu ZX, Ma HJ, Wang DF. (2005). Observation on effect of compound Danshen droplet-pill combined with trimetazidine in treating senile unstable angina pectoris. Zhongguo Zhong Xi Yi Jie He Za Zhi 25:787–9.
  • Song M, Hang TJ, Zhang Z, Chen HY. (2007). Effects of the coexisting diterpenoid tanshinones on the pharmacokinetics of cryptotanshinone and tanshinone II A in rat. Eur J Pharm Sci 32:247–53.
  • Stedman C. (2002). Herbal hepatotoxicity. Semin Liver Dis 22:195–206.
  • Su CC, Lin YH. (2008). Tanshinone II A inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. Int J Mol Med 22:357–61.
  • Tang F, Wu X, Wang T, Wang P, Li R, Zhang H, Gao J, Chen S, Bao L, Huang H, Liu P. (2007). Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul Pharmacol 46:427–38.
  • Ueng YF, Kuo YH, Peng HC, Chen TL, Jan WC, Peter Guengerich F, Lin YL. (2003). Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2. Xenobiotica 33:603–13.
  • Ueng YF, Kuo YH, Wang SY, Lin YL, Chen CF. (2004). Induction of CYP1A by a diterpene quinone tanshinone II A isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice. Life Sci 74:885–96.
  • Wu T, Ni J, Wu J. (2008). Danshen (Chinese medicinal herb) preparations for acute myocardial infarction. Cochrane Database Syst Rev 16:CD004465.
  • Xu Y, Feng D, Wang Y, Lin S, Xu L. (2008). Sodium tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma/STAT1 pathways. J Clin Immunol 28:512–9.
  • Yang XF, Wang NP, Lu WH, Zeng FD. (2003). Effects of Ginkgo biloba extract and tanshinone on cytochrome P-450 isozymes and glutathione transferase in rats. Acta Pharmacol Sin 24:1033–8.
  • Zhang Z, Fasco MJ, Huang Z, Guengerich FP, Kaminsky LS. (1995). Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe. Drug Metab Dispos 23:1339–46.
  • Zhou L, Zuo Z, Chow MS. (2005). Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.